Talphera, Inc. Reveals Two Significant Abstracts for AKI & CRRT 2026 Conference Talphera, Inc. announces its two abstracts accepted for presentation at the AKI & CRRT 2026 conference in San Diego, focusing on innovative renal therapies.

Talphera, Inc. Reveals Two Significant Abstracts for AKI & CRRT 2026 Conference #United_States #San_Mateo #Talphera #Niyad #Nafamostat

Talphera Reports Strong 2025 Financial Results and Clinical Study Update Talphera, Inc. announces its fourth quarter and full year 2025 financial results, highlighting key developments in their clinical trials and company growth.

Talphera Reports Strong 2025 Financial Results and Clinical Study Update #United_States #San_Mateo #Talphera #Niyad #Nafamostat

Talphera to Host Virtual Event Discussing Niyad® in Renal Therapy Innovations on March 23, 2026 Talphera, Inc. announces a virtual investor and analyst event on March 23, 2026, featuring experts discussing Niyad® for Continuous Renal Replacement Therapy.

Talphera to Host Virtual Event Discussing Niyad® in Renal Therapy Innovations on March 23, 2026 #USA #San_Mateo #Talphera #Nafamostat #Niyad®

Talphera Reaches Halfway Point in NEPHRO-CRRT Enrollment for Critical Trial Talphera, Inc. has successfully enrolled 35 out of 70 patients in their NEPHRO-CRRT trial, a key step towards potential FDA approval for a new anticoagulant therapy.

Talphera Reaches Halfway Point in NEPHRO-CRRT Enrollment for Critical Trial #USA #San_Mateo #Talphera #Nafamostat #NEPHRO-CRRT

Talphera Inc. Reaches Key Milestone in NEPHRO CRRT Trial with 17 Patient Enrollments Talphera, Inc. announced the successful enrollment of 17 patients in its pivotal NEPHRO CRRT clinical trial, nearing its goal toward completion by 2025.

Talphera Inc. Reaches Key Milestone in NEPHRO CRRT Trial with 17 Patient Enrollments #United_States #Talphera #Niyad #San_Mateo,_California #Nafamostat

Talphera, Inc. Reports Financial Results and Corporate Updates for Q1 2025 Talphera, Inc. reveals its financial performance for the first quarter of 2025, showcasing key developments and future plans for innovative therapies.

Talphera, Inc. Reports Financial Results and Corporate Updates for Q1 2025 #United_States #San_Mateo #Talphera #Niyad #Nafamostat